Is elderberry safe to consume in Australia?

Ripe, heat-processed elderberries and elderflowers have a well-established safety record at typical dietary amounts. Raw or unprocessed berries contain cyanogenic glycosides (primarily sambunigrin) that can cause nausea and vomiting, so proper preparation matters. Most commercial products sold in Australia use heat-treated or extracted material. If you have specific health concerns, speak with a qualified healthcare practitioner before adding any new supplement to your routine.

Are elderberry products regulated by the TGA?

Yes. Most elderberry products in Australia are sold as Listed complementary medicines under the ARTG (identifiable by an 'AUST L' number). The Listed pathway requires safety and GMP compliance, but does not require pre-market efficacy evidence. Manufacturers must restrict label claims to the TGA's permitted indications list and cannot make specific disease or therapeutic claims without registered-medicine status.

What does the clinical research on elderberry actually show?

The majority of human trials have looked at elderberry in the context of upper respiratory illness. Some small randomised controlled trials and a 2019 meta-analysis (Hawkins et al.) reported reduced symptom duration, but those studies are generally small, use different preparations and doses, and carry notable risk-of-bias concerns. A comprehensive independent systematic review has not yet been completed. The evidence is interesting but not yet strong enough to support confident clinical conclusions.

Can elderberry products claim to treat colds or flu in Australia?

No — not under a Listed (AUST L) registration. Listed complementary medicines are restricted to general well-being or traditional-use style indications. A specific claim to treat, prevent or reduce the risk of influenza or another named condition would require Registered (AUST R) medicine status and a higher level of supporting clinical evidence. The TGA actively monitors and enforces this distinction.

Are there any Australian import restrictions on elderberry, like there are for kava?

No. Elderberry does not face the kind of specific import controls that apply to kava under the Customs (Prohibited Imports) Regulations 1956. Elderberry is freely available in Australia. The regulatory framework that applies is about what claims manufacturers can make on labels and in advertising, not about restricting supply of the ingredient itself.

Elderberry: Traditional Use, Constituents and Evidence

By Naomi Ellison · 2 July 2026 · 7 min read

a black and white photo of a man looking through a microscope

My nan kept a elderberry bush at the back fence , deep purple, almost black berries by late summer, and she'd strip them every year with the quiet certainty of someone who didn't need a reason beyond "that's what you do." I didn't question it as a kid. Years later, reading through 19th-century botanical texts, I kept finding the same plant: Sambucus nigra, European elder, woven into folk pharmacopoeias from the British Isles to Central Europe like it had always been there. Which, more or less, it had.

This article isn't a case for elderberry as a remedy. What it is, honestly, is an attempt to lay out what the plant actually contains, how it's been used historically, and where formal research currently stands , including where that research falls short. There's a lot of noise around elderberry products in Australia. Some of it is warranted enthusiasm; some of it strays into territory that should give us pause.

A very long tradition

Sambucus nigra (family Adoxaceae) is a deciduous shrub or small tree native to Europe, western Asia and North Africa. Recorded medicinal uses stretch back at least to the ancient Greeks , Hippocrates reportedly referred to elder as his "medicine chest." By the 17th century, John Evelyn had written that elder alone could furnish a complete materia medica, which is the kind of claim that says as much about the plant's cultural prominence as it does about anything clinical.

Traditional applications vary widely by plant part. Flowers (elderflower) were used in topical preparations and teas. Leaves and bark; containing sambunigrin and other cyanogenic glycosides, were used far more cautiously, and raw berries were typically cooked before consumption to reduce the same compounds. The ripe, heat-treated berry became the main preparation in European folk traditions and, eventually, the primary subject of modern phytomedicine research.

It's worth stating plainly: traditional use does not constitute clinical evidence. It tells us a plant was considered useful, which makes it worth studying. That's different from proof of effect.

Key constituents of Sambucus nigra berries

The phytochemical profile of elderberry is reasonably well-characterised. The constituents most often referenced in the research literature include:

Anthocyanins, primarily cyanidin-3-glucoside and cyanidin-3-sambubioside, the pigments responsible for the deep purple-black colour. These are the most-studied compounds in elderberry and account for a significant portion of its antioxidant activity in laboratory assays.
Flavonols; quercetin, rutin and kaempferol glycosides are present in meaningful concentrations.
Phenolic acids, including chlorogenic acid.
Polysaccharides, some research has focused on these as potential modulators of immune-cell activity in vitro, though the picture is still forming.
Vitamins and minerals; vitamin C, vitamin A and potassium are present in quantities consistent with a nutritious dark berry, which is not a trivial point.

The anthocyanin content varies considerably by cultivar, growing conditions, ripeness and, critically, processing method. This is a persistent problem in the research base: studies often don't use standardised extracts, making direct comparison difficult. Our glossary entry on standardised extracts covers why this matters for interpreting phytomedicine research generally.

Elderflowers have a somewhat different profile, richer in flavonoids like quercetin and kaempferol, and are the subject of separate (and thinner) research literature.

What the research has looked at

The bulk of published human research on elderberry has concentrated on respiratory illness outcomes; specifically symptom duration and severity. The most-cited trial in this space is a 2016 randomised controlled trial published in Nutrients (Tiralongo et al.), which looked at elderberry supplementation in air travellers. That study reported shorter cold duration in the elderberry group. A 2019 meta-analysis by Hawkins, Baker, Cherry and Dunne in Complementary Therapies in Medicine pooled several trials and reported a significant overall reduction in upper respiratory symptoms.

But, and this is where we need to be careful with that claim, most individual trials are small, short-duration, use different preparations at different doses, and several have industry funding or other risk-of-bias concerns. The meta-analysis authors themselves flag heterogeneity across included studies as a major limitation. A 2021 Cochrane-style systematic review protocol was registered for this question (PROSPERO CRD42021256933) but to my knowledge a completed review has not yet been published. That gap matters. Enthusiastic headlines about elderberry consistently outpace what the available trial data can actually support.

Laboratory (in vitro) studies on elderberry's effect on viral adhesion and cytokine activity are interesting mechanistically, but in vitro findings do not translate directly to clinical outcomes in humans. I've lost count of how many times I've seen a cell-culture result cited as if it were a human trial. It isn't.

Research on elderberry's antioxidant capacity is solid at the assay level; the anthocyanin content genuinely produces high ORAC and DPPH scores. Whether dietary antioxidant activity translates to measurable physiological outcomes in well-nourished adults is a separate and genuinely contested question in nutritional science.

Elderberry as a phytomedicine: the regulatory picture in Australia

In Australia, elderberry products are almost universally sold as listed complementary medicines (ARTG Listed, or "L" products). The ARTG listing pathway, governed by the Therapeutic Goods Administration, does not require pre-market efficacy evidence. It requires manufacturers to demonstrate safety, Good Manufacturing Practice compliance, and that any label claims are drawn from the TGA's permitted indications list. Companies cannot make therapeutic claims that go beyond what the TGA has approved for listed goods.

This means that many elderberry products on Australian shelves carry general well-being or "traditional use" style indications rather than specific disease claims. A product label stating it "traditionally used in Western herbal medicine" is operating within that framework. A label claiming to treat, prevent or reduce risk of influenza would be making a therapeutic claim that requires a higher level of evidence and a different regulatory pathway (a registered, "AUST R" medicine).

Consumers are sometimes confused by this distinction, and honestly, the labelling can be ambiguous enough to blur it. The TGA has guidance on permitted indications for listed medicines on its website, and it's worth reading if you're trying to evaluate a product's evidentiary basis.

There are no specific Australian import restrictions on elderberry comparable to, say, kava (which faces strict import controls under the Customs (Prohibited Imports) Regulations 1956 and a dedicated commercial importation scheme). Elderberry products are widely and legally available. The regulatory constraint is on the claims made, not the supply.

Preparation and the raw berry question

Raw, unripe elderberries contain sambunigrin, a cyanogenic glycoside that can cause nausea and vomiting. This is not a minor footnote; there are documented cases of adverse events following consumption of raw elderberry preparations, including a 1984 report in the US (Morbidity and Mortality Weekly Report) involving elderberry juice made without heat treatment. Heat processing during cooking or extraction substantially degrades these compounds. Most commercial elderberry products use heat-processed or extracted material, and traditional folk preparations almost universally involved cooking the berries. The raw-berry-juice trend occasionally seen in some wellness circles is one I'd argue is worth approaching with real caution.

The flowers and ripe cooked berries have a good safety record at typical consumption levels. As with all botanical preparations, the devil is in the preparation method and dose, and those parameters are often underspecified in both folk tradition and published research.

Where elderberry fits in the broader phytomedicine picture

Elderberry is a genuinely interesting botanical, historically rich, reasonably well-characterised chemically, and the subject of a small but growing clinical literature. The research is promising enough to justify further rigorous investigation. It is not, at this stage, supported by the kind of large, well-powered, independently replicated trial data that would allow confident claims about specific outcomes.

For those interested in how plant constituents interact with human physiology more broadly, the anthocyanins and flavonols in elderberry sit within the wider polyphenol research space. Some of the mechanistic questions, about absorption, metabolism and tissue distribution; overlap with bioavailability challenges that come up across phytomedicine research generally, including in cannabinoid science.

The honest summary is this: elder has a long, cross-cultural history of use that made it worth studying, some interesting constituent chemistry, and a research base that's growing but still has meaningful limitations. That's actually a reasonably good place for a botanical to be, it means the science is alive. It also means scepticism about strong product claims is warranted.

My nan would have shrugged at all of this and gone back to picking. Fair enough, really.

Sources

, Naomi Ellison, Botanical & phytomedicine writer

Common questions

Is elderberry safe to consume in Australia?: Ripe, heat-processed elderberries and elderflowers have a well-established safety record at typical dietary amounts. Raw or unprocessed berries contain cyanogenic glycosides (primarily sambunigrin) that can cause nausea and vomiting, so proper preparation matters. Most commercial products sold in Australia use heat-treated or extracted material. If you have specific health concerns, speak with a qualified healthcare practitioner before adding any new supplement to your routine.
Are elderberry products regulated by the TGA?: Yes. Most elderberry products in Australia are sold as Listed complementary medicines under the ARTG (identifiable by an 'AUST L' number). The Listed pathway requires safety and GMP compliance, but does not require pre-market efficacy evidence. Manufacturers must restrict label claims to the TGA's permitted indications list and cannot make specific disease or therapeutic claims without registered-medicine status.
What does the clinical research on elderberry actually show?: The majority of human trials have looked at elderberry in the context of upper respiratory illness. Some small randomised controlled trials and a 2019 meta-analysis (Hawkins et al.) reported reduced symptom duration, but those studies are generally small, use different preparations and doses, and carry notable risk-of-bias concerns. A comprehensive independent systematic review has not yet been completed. The evidence is interesting but not yet strong enough to support confident clinical conclusions.
Can elderberry products claim to treat colds or flu in Australia?: No — not under a Listed (AUST L) registration. Listed complementary medicines are restricted to general well-being or traditional-use style indications. A specific claim to treat, prevent or reduce the risk of influenza or another named condition would require Registered (AUST R) medicine status and a higher level of supporting clinical evidence. The TGA actively monitors and enforces this distinction.
Are there any Australian import restrictions on elderberry, like there are for kava?: No. Elderberry does not face the kind of specific import controls that apply to kava under the Customs (Prohibited Imports) Regulations 1956. Elderberry is freely available in Australia. The regulatory framework that applies is about what claims manufacturers can make on labels and in advertising, not about restricting supply of the ingredient itself.